“Liquid biopsy” tests using blood samples to screen for multiple types of cancer are attracting much attention, for their potential to catch unseen tumors.

Health insurance premiums in the United States are headed toward a sharp increase in 2026, the biggest leap in about 15 years.

A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its early stages, when treatment may help save lives, according to results presented today at the 39th annual International Bubble Conference in Chicago.

“It is a nightmare waking up every day wondering if some people halfway across the country will approve what my doctors have said is my only chance.”

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test.

Prostate cancer treatment continues to evolve, and patients have more options than ever; however, understanding the risks and benefits of each approach is critical.

Older individuals up to the age of 80 who are eligible for lung surgery may achieve a survival benefit from lung cancer screening comparable to that for younger patients, according to the results of a multicenter cohort study from the United Kingdom presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC; Abstract PL03.19).

Consumers can now purchase Exact Sciences’ liquid biopsy early detection test, Cancerguard, and get an indication of whether they might have one of 50 different cancers included in the test’s analysis.

Getting a cancer diagnosis can be overwhelming and frightening. This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.

Appendix cancer is a condition that, until recently, was so rare that most people never gave it a second thought.